Children's FLONASE Product Overview

Available for children ages 4+

Full prescription-strength
Works to block 6 key inflammatory mediators—not just histamine*^1-4
Treats itchy, watery eyes^5-9

Read more about Flonase products

FLONASE SENSIMIST Allergy Relief

Find out how FLONASE SENSIMIST Allergy Relief can help your patients.

Find out more

Children’s FLONASE SENSIMIST Allergy Relief

Find out how Children’s FLONASE SENSIMIST Allergy Relief can help your patients.

Find out more

FLONASE Allergy Relief

Find out how FLONASE Allergy Relief can help your patients.

Find out more

Allergic Rhinitis Overview

Find out more about allergic rhinitis

Find out more

Causes and Mechanisms

Find out more about the science of allergic rhinitis

Find out more

Patient care resources

Download resources for your patients.

Find out more

Patient FSA / HSA Eligible Product

This product is eligible for Flexible Spending Account (FSA) and Health Savings Accounts (HSA)

Resulting from the CARES Act recently passed by congress, you can now use your FSA and HSA tax-preferred savings account to purchase certain OTC products such as Flonase, Nicorette, Nicoderm, Advil, Voltaren, and Denture Care Products. Your plan details may vary, so make sure to save your receipt and check with your benefits or health provider for eligibility. Please visit our page on Using My FSA/HSA.

*Mechanism vs most allergy pills. Children’s FLONASE acts on multiple inflammatory mediators (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.

References

Derendorf, H. and Meltzer, E. O. Molecular and Clinical Pharmacology of Intranasal Corticosteroids: Clinical and Therapeutic Implications. Allergy: European Journal of Allergy and Clinical Immunology. 63(10): 1292-1300, 2008.
Gelfand, E. W. Inflammatory Mediators in Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 114(5 SUPPL.): S135-S138, 2004.
White, M. V. and Kaliner, M. A. Mediators of Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 90(4 II): 699-704, 1992.
Bachert, C. and Geveart, P. Effect of Intranasal Corticosteroids on Release of Cytokines and Inflammatory Mediators. Allergy: European Journal of Allergy and Clinical Immunology, Supplement. 54(57): 116-123, 1999.
Haye, R. and Gomez, E. G. A Multicentre Study to Assess Long-Term Use of Fluticasone Propionate Aqueous Nasal Spray in Comparison With Beclomethasone Dipropionate Aqueous Nasal Spray in the Treatment of Perennial Rhinitis. Rhinology. 31(4): 169-174, 1993.
Bernstein, D. I., Levy, A. L., Hampel, F. C., Baidoo, C. A. et al. Treatment With Intranasal Fluticasone Propionate Significantly Improves Ocular Symptoms in Patients With Seasonal Allergic Rhinitis. Clinical and Experimental Allergy. 34(6): 952-957, 2004.
DeWester, J., Philpot, E. E., Westlund, R. E., Cook, C. K. et al. The Efficacy of Intranasal Fluticasone Propionate in the Relief of Ocular Symptoms Associated With Seasonal Allergic Rhinitis. Allergy and Asthma Proceedings. 24(5): 331-337, 2003.
Data on file, GlaxoSmithKline. (GSK: Result Summary for Study FNM30034. Http://Www.Gsk-Clinicalstudyregister.Com/. 5-12-2005).
FLONASE Drug Facts Label.

PM-US-FLO-20-00220